Articles tagged with Neurological Disorders
Researchers have made a promising breakthrough in understanding the origins of mirror movements disorder by identifying the cellular mechanism behind the condition. A defect in axon guidance is revealed to be the underlying cause of the disorder, which can lead to difficulties in performing tasks requiring left-right coordination.
A new study published in the Journal of the American College of Cardiology found that subclinical atherosclerosis is independently associated with the risk of dying from any cause. The study also showed that monitoring the progression of atherosclerosis can improve the prediction and prevention of death from any cause.
A study published in JACC demonstrates that subclinical atherosclerosis burden and progression independently predict death from any cause. Asymptomatic individuals with high carotid plaque burden and coronary artery calcification are at increased risk of mortality.
Researchers found that weekend warrior and regular physical activity patterns were associated with substantially lower risks of over 200 diseases. Weekend warrior activity was found to be just as effective at decreasing risk as more evenly distributed exercise activity.
A team of scientists has identified a new genetic mutation in the SGIP1 gene that may cause early-onset Parkinsonism. The mutation affects brain cell communication, leading to synaptic dysfunction and recessive Parkinsonism. This discovery provides new insights into the disease's development and potential treatment strategies.
A cohort study found a significant association between maternal influenza infection during pregnancy and an increased risk of childhood seizures. The study suggests that maternal influenza may affect childhood neurological development, particularly for febrile seizures, but not epilepsy.
UTHealth Houston researchers are exploring new pathways to treat Alzheimer's disease through multiple projects funded by the Texas Alzheimer's Research and Care Consortium. Studies aim to investigate ACSL4 gene, delirium's impact on disease progression, biological aging, and noninvasive diagnosis methods.
A recent study by FAU researchers links copper regulation to neurodegenerative disorders like Alzheimer's. The team discovered that a specific gene, swip-10, plays a crucial role in maintaining the balance of copper in cells, which can prevent mitochondrial dysfunction and oxidative stress.
The NEXUS exposomics coordinating center aims to deepen understanding of how environmental and social determinants impact health. Led by USC's Rima Habre, the center brings together diverse scientists to study place-based exposures using geospatial methods.
A clinical trial found that an oral cancer drug reduced nosebleed severity and improved quality of life in patients with hereditary hemorrhagic telangiectasia (HHT). The PATH-HHT study showed significant improvements in disease manifestations, including severe nosebleeds and chronic gastrointestinal bleeding.
Researchers developed a multi-variable model called Hear-MHE that analyzes speech patterns to identify symptoms of minimal hepatic encephalopathy. The test shows promise in predicting overt hepatic encephalopathy and could lead to earlier diagnosis and improved treatment.
Scientists at Kyoto University's Institute for Integrated Cell-Material Sciences have discovered a protein complex that regulates phospholipid scrambling, a process important for blood clotting and unwanted cell removal. The finding could lead to new treatments for diseases like epilepsy and anemia.
Researchers at Karolinska Institutet successfully used gene therapy to improve vision in 11 out of 12 patients with Bothnia dystrophy, a form of hereditary blindness. The treatment involved injecting a specially designed virus under the retina, which produced normal protein and restored visual function.
Research found a positive association between outdoor nighttime light pollution and Alzheimer's disease prevalence, particularly in those under 65. Higher light intensity was associated with greater AD prevalence in this age group, suggesting they may be more vulnerable to the effects of light exposure.
Researchers at the University of Copenhagen have identified a protein called OSER1 that influences longevity in various animals and humans. The discovery opens up possibilities for understanding age-related diseases and developing new drug targets.
Researchers led by Daniela Vallentin successfully rewired zebra finches' brains using optogenetics, expanding their vocal repertoire. The findings have implications for human aging and potential therapies for neurodegenerative diseases and learning impairments.
A study published in The EMBO Journal reveals that PQBP3 plays a crucial role in stabilizing the nuclear membrane, which is destabilized in senescent cells and contributes to neurodegenerative disorders. PQBP3's dysfunction may lead to the degradation of Lamin B1, a protein essential for maintaining the nuclear membrane.
A clinical trial led by UC San Francisco aims to develop new therapies for progressive supranuclear palsy, with a focus on reducing time to find effective treatments and increasing diverse participant enrollment. The five-year grant could lead to the first effective drugs for this incurable neurodegenerative disorder.
Researchers discovered that the blood coagulation protein fibrin causes unusual clotting and inflammation in COVID-19, suppressing the body's ability to clear the virus. A promising therapeutic strategy has been identified, targeting fibrin to combat these deleterious effects.
A new study published in the American Journal of Clinical Nutrition found that pesco-vegetarian diets are associated with a lower risk of mortality and certain neurological conditions in elderly individuals. The study analyzed data from over 88,000 subjects and found that pesco-vegetarians had an 18% lower risk of death compared to non...
Researchers at Åbo Akademi University have discovered a crucial protein, TLNRD1, that helps maintain blood vessel stability in the brain. The study highlights the potential for targeted molecular therapies to improve patient outcomes in CCM disease.
Researchers at University of California - San Diego have discovered a link between environmentally induced autism and altered neurotransmitter expression in the brain. The study suggests that manipulating these neurotransmitters early in development can prevent autistic-like behaviors.
Researchers found that people with chronic diabetes complications are up to three times more likely to have a mental health condition, while those with mental health disorders are up to two and a half times more likely to experience sustained diabetes complications. The study highlights the importance of screening for both risk factors.
A scoping review from the University of Gothenburg found that music-based movement therapy, known as the Ronnie Gardiner Method, can improve rehabilitation outcomes in individuals with brain disorders. The method has been shown to be challenging, motivating, and enjoyable for participants, leading to improved recovery and quality of life.
A new study has identified six genetic regions associated with normal pressure hydrocephalus (NPH), a chronic neurological syndrome affecting gait, memory, and bladder control. The study provides new insights into the genetic background of NPH, which remains unclear despite previous research.
Researchers at CUNY ASRC identify distinct histone tag in adult oligodendrocyte progenitor cells that regulates their proliferation and may lead to innovative therapies for neurodegenerative diseases. The discovery holds promise for advancing myelin repair and improving patient outcomes.
Parents who struggle with alcohol use disorders can pass along symptoms of early aging to their children, affecting them well into adulthood. These accelerated aging effects include high cholesterol, heart problems, arthritis, and early onset dementia.
A new study found that mTORC1 activity correlates with classical biometrics, such as height and macrocephaly, as well as specific neuropsychiatric diseases like anxiety and autism. The research suggests that human variability of mTORC1 gain of function may predict medication response.
A study published in Cardiovascular Diabetology found that higher blood glucose levels at admission significantly increase the risk of a poor functional prognosis or death within three months of an ischemic stroke. The study revealed that even a 10% increase in glucose levels raises the risk by 7%, and mortality risk by 88%.
Researchers found that dopamine treatment increased neprilysin levels and reduced beta-amyloid plaques in mouse brains, improving memory function. Long-term L-DOPA treatment also showed improved cognitive performance in mice.
Researchers at UC Davis have developed a new method called CaST to track the activation of brain neurons and biomolecules by psychedelic drugs. The tool allows scientists to study the cellular mechanisms behind psychedelic treatments for brain disorders, such as depression and post-traumatic stress disorder.
Researchers identified a common genetic variation that appears to protect against ALS by reducing levels of a protein blocking the IGF-1 signaling pathway. This finding suggests a potential new approach to targeting IGF-1 as a treatment for ALS.
A new study using live mice and influenza virus sheds light on how maternal immune response affects fetal brain development. Researchers found that only a subset of severe infections can cause changes in the developing fetal brain, increasing the risk for neurodevelopmental disorders like schizophrenia and autism spectrum disorder.
A preclinical study led by Weill Cornell Medicine researchers found that the iron-chelating drug deferiprone can selectively target and kill ovarian cancer cells. By starving cancer cells of iron, deferiprone triggers a cellular stress response, prompting the immune system to attack them.
Viji Santhakumar, a UCR professor, has been awarded a $3.5 million NIH grant to study brain circuit function and its impact on memory formation and cognitive deficits in diseases like epilepsy and Alzheimer's disease.
The PD GENEration study has found that 13% of participants have a genetic form of Parkinson's disease, significantly higher than previous estimates. The study, which reached its goal of 15,000 participants ahead of schedule, provides insights into the genetics of the disease and its potential for precision medicine.
Microglia establish contact with neurons through tunnelling nanotubes to clear toxic protein aggregates, reducing oxidative stress and restoring vital functions. Healthy mitochondria are also transferred from microglia to affected neurons, preserving energy production and neuronal survival.
Scientists successfully mapped transcriptomes from 1.3 million brain cortex cells to gain molecular insights into Alzheimer's vulnerability and resilience. The resulting atlas holds promise for gene and molecular discovery across pathways affecting brain health.
A new study reveals specific brain regions and cell types that are vulnerable to Alzheimer's disease, while others show resilience. Gene expression analysis and lab experiments highlight the role of Reelin in neuronal vulnerability and choline/antioxidants in sustaining cognition.
A machine learning algorithm was trained to predict individuals with functional neurological disorder (FND) by analyzing their brain structure. The algorithm achieved significant above-chance accuracy in classifying FND participants against healthy controls and psychiatric samples, highlighting the importance of considering both brain ...
Researchers at KAUST have developed NanoRanger, an accurate and rapid method for genetically diagnosing Mendelian genetic disorders. This breakthrough enables diagnosis in just 12 minutes, providing a detailed picture of the genomic disorder.
A study published in JAMA Network Open found that years of high systolic blood pressure increase the risk of stroke, with Black and Hispanic patients facing a higher risk. Early diagnosis and controlled high blood pressure are crucial to preventing stroke, especially in these populations.
Salk researchers created tools to study neuropeptides, finding they control the brain's fear response in mice. Neuropeptides are released during a mild stimulus, triggering fear behaviors, which can be reduced by silencing their release.
Researchers developed a new NIPT-based method that reveals 33 pathogenic copy number variations (CNVs) in the Duchenne muscular dystrophy (DMD) gene. This study provides valuable insights into the frequency and spectrum of maternal CNV carriers in the Chinese population.
Children with conduct disorder show significant reductions in brain surface area and volume of subcortical regions compared to typically developing children. These findings suggest that the development of the brain is different in individuals with CD, highlighting the need for further research into this under-recognized condition.
Researchers at Rice University have developed a nanosized sensor that records the electrical activity of spinal neurons in action. The sensor, called spinalNET, can track individual neurons over multiple days, providing valuable insights into the mechanisms controlling movement and sensation in the spinal cord.
Researchers identified a fundamental imbalance in immune responses that patients with lupus make, leading to insufficient activation of the aryl hydrocarbon receptor pathway. This imbalance can be corrected by reprogramming disease-causing cells into Th22 cells promoting wound healing, offering a potential cure for lupus.
A study published in Nature Communications has identified a neurological mechanism underlying anorexia nervosa and found a possible cure using donepezil, a medication increasing acetylcholine levels. Ongoing studies show positive results for patients with severe anorexia nervosa treated with low doses of donepezil.
Researchers discuss the critical role of the retinal pigmented epithelium in human vision and its susceptibility to aging. The study highlights the importance of understanding molecular and cellular mechanisms driving age-related pathological changes in vision decline.
A recent study found that cerebellar neurons communicate with other brain regions in different ways, leading to various motor defects. The researchers discovered unique activity patterns responsible for different abnormal movements, providing a foundational framework for new treatment approaches.
Researchers found individuals with schizophrenia struggle to discriminate between reward levels, leading to apathy and motivation deficits. The study suggests potential treatments, including brain stimulation and targeted psychotherapy.
A study by Cold Spring Harbor Laboratory researchers has discovered a crucial receptor protein that regulates the timing of temporary neural connections in the developing brain. Without this protein, mice exhibit atypical behaviors, highlighting its potential role in shaping brain circuits and preventing neurodevelopmental disorders.
Researchers have recognized the dynamic and active role of brain extracellular space (ECS) in regulating neural activity. Dysregulation of ECS contributes to neurological disorders, suggesting therapeutic modulation as a novel treatment pathway.
A new study found that claustrum neurons regulate engagement with sensory information during tasks and sleep. Increased activity in these neurons reduces impulsivity and improves performance.
Researchers at the Gwangju Institute of Science and Technology (GIST) have developed an innovative robotic rehabilitation system called SPINDLE to enhance the strength and dexterity of individuals with tremors. The study revealed significant benefits, including improved motor control, coordination, and neuroplasticity.
A new global definition of sarcopenia is proposed, aiming to unify research and clinical practice. The definition may help identify low muscle mass or strength in older people, increasing the risk of poor outcomes such as fragility and disability.
Researchers at Boston University developed an AI model that analyzes speech patterns to predict the likelihood of Alzheimer's disease in patients with mild cognitive impairment. The model achieved an accuracy rate of 78.5% and could potentially revolutionize dementia screening, making it more accessible and efficient.
Researchers at U of T have harnessed CRISPR to efficiently and precisely control RNA splicing, enabling the systematic interrogation of gene functions and correction of splicing deficiencies in diseases. This new tool allows for targeted activation or repression of alternative exons with high specificity.
Researchers have developed a blood test that can detect rare forms of dementia, such as frontotemporal dementia (FTD) and progressive supranuclear palsy (PSP), as well as amyotrophic lateral sclerosis (ALS). The test uses biomarkers, including tau and TDP-43 proteins, to identify underlying pathology.
A Kobe University study finds that a new treatment for neuromyelitis optica spectrum disorder shifts the balance of immune cells, increasing anti-inflammatory signals. The discovery may enable clinicians to determine treatment effectiveness and move towards personalized medicine for autoimmune diseases.